AI
LMAT icon

Atria Investments’s LeMaitre Vascular LMAT Stock Holding History

Atria Investments’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$694K Sell
7,230
-382
-5% -$39.2K 0.01% 1327
2026
Q1 		$831K Buy
7,612
+2,459
+48% +$234K 0.01% 1163
2025
Q4 		$418K Sell
5,153
-170
-3% -$14.6K ﹤0.01% 1551
2025
Q3 		$466K Sell
5,323
-1,095
-17% -$97.8K 0.01% 1455
2025
Q2 		$533K Sell
6,418
-85
-1% -$7.1K 0.01% 1384
2025
Q1 		$546K Sell
6,503
-1,985
-23% -$185K 0.01% 1309
2024
Q4 		$782K Sell
8,488
-365
-4% -$35.1K 0.01% 1113
2024
Q3 		$822K Buy
8,853
+2,701
+44% +$234K 0.01% 1079
2024
Q2 		$506K Buy
+6,152
New +$452K 0.01% 1294

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Atria Investments's LMAT Position: Q2 2026 in Review

Atria Investments reduced its LeMaitre Vascular (LMAT) stake by 5% in Q2 2026, selling an estimated $39.2K and leaving 7,230 shares worth $694K. The position accounts for 0.01% of the portfolio, ranked #1327.

Atria Investments first reported a position in LMAT in Q2 2024 and has held it in 9 quarters since. The position peaked at $831K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Atria Investments held 7,230 shares of LeMaitre Vascular worth $694K as of Q2 2026.
  • Atria Investments sold 382 LeMaitre Vascular shares in Q2 2026, an estimated $39.2K.
  • LeMaitre Vascular made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1327 holding.
  • Atria Investments first reported a position in LeMaitre Vascular in Q2 2024 and has held it in 9 quarters since.
  • Atria Investments's LeMaitre Vascular position peaked at $831K in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.